KRT14 and skin basal cell carcinoma: This was accompanied by a significant increased percentage of YAP positive nuclei within the extending BCC masses of tamoxifen-treated compared to vehicle-treated K14-CreER/Rosa-SmoM2 skin (Fig 1B and 1E; P < 0.01, N = 3).